News | August 13, 2025
Apollo Hospitals Q1 FY26 PAT up 42% to Rs. 433 Cr
Apollo has also announced plans to add over 4,300 beds in the next five years with an investment of over Rs. 7,600 crore
Apollo has also announced plans to add over 4,300 beds in the next five years with an investment of over Rs. 7,600 crore
EBITDA stood at Rs. 100.1 crore with a margin of 16.1 per cent
Ranibizumab is a recombinant humanized IgG1 monoclonal antibody fragment that binds to and inhibits vascular endothelial growth factor A
Minister releases five breakthrough veterinary technologies to strengthen diagnostics and combat antimicrobial resistance
Dr. Venkatraman brings over 25 years of experience in small molecule and Biologics drug development, manufacturing, and advancing strategic growth initiatives
During this quarter, the company achieved a key milestone of reaching 1,000 DCGI approvals
Hikal has reported total income of Rs. 381.4 crores during the period ended June 30, 2025
With this addition, the company’s total Installed MCC Capacity will rise to 30,000 MTPA
Cenexi reports an EBITDA breakeven for the quarter
Athena is also exploring the use of this technology for expanded carrier screening
Subscribe To Our Newsletter & Stay Updated
